TTY Biopharm Company Limited (TPEX:4105)
Taiwan · Delayed Price · Currency is TWD 83.70
-0.40 (-0.48%)
At close: Feb 11, 2026
TTY Biopharm Company Market Cap
TTY Biopharm Company has a market cap or net worth of 20.81 billion as of February 13, 2026. Its market cap has increased by 11.16% in one year.
Market Cap
20.81B
Enterprise Value
20.83B
Revenue
6.50B
Ranking
n/a
PE Ratio
11.64
Stock Price
83.70
Market Cap Chart
Since July 3, 2003, TTY Biopharm Company's market cap has increased from 3.05B to 20.81B, an increase of 582.55%. That is a compound annual growth rate of 8.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 20.81B | 2.70% |
| Dec 31, 2025 | 20.26B | 11.95% |
| Dec 31, 2024 | 18.10B | -9.45% |
| Dec 29, 2023 | 19.99B | -3.60% |
| Dec 30, 2022 | 20.74B | 21.22% |
| Dec 30, 2021 | 17.11B | 0.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 60.77B |
| Center Laboratories | 29.86B |
| Grape King Bio | 18.07B |
| Alar Pharmaceuticals | 17.87B |
| ScinoPharm Taiwan | 17.12B |
| Synmosa Biopharma | 16.25B |
| YungShin Global Holding | 14.73B |
| Foresee Pharmaceuticals | 13.33B |